Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Oncodesign to buy GSK's French research center Oncodesign has agreed to acquire the François Hyafil Research Centre located in Villebon-sur-Yvette (Essonne) from GSK, part of the Paris Saclay innovation cluster, including transfer of the team of highly qualified drug discovery staff located at the site (anticipated to be 57 employees).
Contract Research & Services > Contract Research > News
Bristol-Myers to test Opdivo with Nektar Therapeutics drug in five tumor types By PBR Staff Writer
Bristol-Myers Squibb (BMS) is evaluating the use of its cancer immunotherapy, Opdivo, in combination with an experimental drug from Nektar Therapeutics to treat several cancers.
Contract Research & Services > Contract Research > News Evotec forms research collaboration with Inserm Transfert in oncology Evotec has entered into a research collaboration with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm).
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Evotec forms research collaboration with Inserm Transfert in oncology
Evotec has entered into a research collaboration with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm).
Contract Research & Services > Contract Research > News
Takeda, Affilogic partner to develop CNS therapies
Takeda Pharmaceutical Company and Affilogic have entered into a research collaboration to explore using Affilogic’s Nanofitins platform in therapies targeting the central nervous system (CNS).
Contract Research & Services > Contract Research > News
Bayer, Evotec join hands to develop new treatments for kidney diseases
By PBR Staff Writer
Bayer and German firm Evotec have partnered to develop to new treatments for kidney diseases.
Contract Research & Services > Contract Research > News
Redx Pharma confirms potential role for Porcupine inhibitor in cancer immunotherapy
Redx Pharma has confirmed that its lead cancer treatment, the Porcupine inhibitor (RXC004), has a potential role in cancer immunotherapy.
Contract Research & Services > Contract Research > News
Sanofi, Verily Life Sciences create new JV to develop diabetes management platform
By PBR Staff Writer
French pharmaceutical firm Sanofi and Alphabet subsidiary Verily Life Sciences have launched a new joint venture (JV) called Onduo, to develop comprehensive diabetes management platform.
Contract Research & Services > Contract Research > News
Novo Nordisk Pharmatech A/S Attending Upcoming Exhibitions and Conferences
Novo Nordisk Pharmatech A/S, part of Novo Nordisk, specialises in supplying ingredients to the biopharmaceutical and pharmaceutical industries.This October it will be participating in the CPHI worldwide exhibition in Barcelona, and BioProcess International USA conference and exhibition.
Contract Research & Services > Contract Research > Press Releases
Biothera collaborates with Merck for combination cancer immunotherapy trials in multiple indications
Biothera Pharmaceuticals announced a collaboration with Merck to expand the companies’ ongoing clinical program evaluating KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 inhibitor, in combination with Biothera’s Imprime PGG, a Pathogen Associated Molecular Patterning molecule, or PAMP.
Contract Research & Services > Contract Research > News
Xycrobe signs research deal with Johnson & Johnson Consumer
Xycrobe Therapeutics has entered into a research agreement with Johnson & Johnson Consumer.
Contract Research & Services > Contract Research > News
Almac's Colon Cancer Recurrence Assay in Journal of Clinical Oncology
Almac Publish Second Validation of Stage II Colon Cancer Recurrence Assay in the Journal of Clinical Oncology.
Contract Research & Services > Contract Research > Press Releases
View all Contract Research news or find news targeted to your interests